A qualitative transcriptional signature for the histological reclassification of lung squamous cell carcinomas and adenocarcinomas

被引：0

作者：

Xin Li

Gengen Shi

Qingsong Chu

Wenbin Jiang

Yixin Liu

Sainan Zhang

Zheyang Zhang

Zixin Wei

Fei He

Zheng Guo

Lishuang Qi

机构：

[1] Harbin Medical University,College of Bioinformatics Science and Technology

[2] Institute of Translational Medicine,Fujian Key Laboratory for Translational Research

[3] Fujian Medical University,Department of Medical Oncology

[4] Harbin Medical University Cancer hospital,Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Department of Epidemiology and Health Statistics, School of Public Health

[5] Fujian Medical University,Department of Bioinformatics, Key Laboratory of Ministry of Education for Gastrointestinal Cancer, School of Basic Medical Sciences

[6] Fujian Medical University,undefined

[7] Key laboratory of Medical Bioinformatics,undefined

[8] Fujian Province,undefined

来源：

BMC Genomics | / 20卷

关键词：

Non-small cell lung cancer; Histological subtype; Pathological assessment; Relative gene expression orderings; Qualitative transcriptional signature;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 18 条

[1] A qualitative transcriptional signature for the histological reclassification of lung squamous cell carcinomas and adenocarcinomas
Li, Xin
Shi, Gengen
Chu, Qingsong
Jiang, Wenbin
Liu, Yixin
Zhang, Sainan
Zhang, Zheyang
Wei, Zixin
He, Fei
Guo, Zheng
Qi, Lishuang
BMC GENOMICS, 2019, 20 (01)
[2] Differential expression of critical cellular genes in human lung adenocarcinomas and squamous cell carcinomas in comparison to normal lung tissues
McDoniels-Silvers, AL
Stoner, GD
Lubet, RA
Ming, Y
NEOPLASIA, 2002, 4 (02): : 141 - 150
[3] The alveolar type II cell is a pluripotential stem cell in the genesis of human adenocarcinomas and squamous cell carcinomas
TenHaveOpbroek, AAW
Benfield, JR
vanKrieken, JHJH
Dijkman, JH
HISTOLOGY AND HISTOPATHOLOGY, 1997, 12 (02) : 319 - 336
[4] Immune cell landscape in therapy-naive squamous cell and adenocarcinomas of the lung
Brcic, Luka
Stanzer, Stefanie
Krenbek, Dagmar
Gruber-Moesenbacher, Ulrike
Absenger, Gudrun
Quehenberger, Franz
Valipour, Arschang
Lindenmann, Joerg
Stoeger, Herbert
Al Effah, Mohamed
Fediuk, Melanie
Balic, Marija
Popper, Helmut H.
VIRCHOWS ARCHIV, 2018, 472 (04) : 589 - 598
[5] Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lung
Luka Brcic
Stefanie Stanzer
Dagmar Krenbek
Ulrike Gruber-Moesenbacher
Gudrun Absenger
Franz Quehenberger
Arschang Valipour
Joerg Lindenmann
Herbert Stoeger
Mohamed Al Effah
Melanie Fediuk
Marija Balic
Helmut H. Popper
Virchows Archiv, 2018, 472 : 589 - 598
[6] Toward an early diagnosis of lung cancer: An autoantibody signature for squamous cell lung carcinoma
Leidinger, Petra
Keller, Andreas
Ludwig, Nicole
Rheinheimer, Stefanie
Hamacher, Juerg
Huwer, Hanno
Stehle, Ingo
Lenhof, Hans-Peter
Meese, Eckart
INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (07) : 1631 - 1636
[7] A rare case of squamous cell carcinoma lung with multiple locoregional recurrences and histological transformation
Niwas, Ram
Chakrabarti, Shibdas
Balasubramanian, Viswesvaran
Sen, Manas Kamal
Suri, Jagdish Chander
LUNG INDIA, 2018, 35 (06) : 511 - 515
[8] Should EGFR mutations be tested in advanced lung squamous cell carcinomas to guide frontline treatment?
Chao-Hua Chiu
Teh-Ying Chou
Chi-Lu Chiang
Chun-Ming Tsai
Cancer Chemotherapy and Pharmacology, 2014, 74 : 661 - 665
[9] Should EGFR mutations be tested in advanced lung squamous cell carcinomas to guide frontline treatment?
Chiu, Chao-Hua
Chou, Teh-Ying
Chiang, Chi-Lu
Tsai, Chun-Ming
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (04) : 661 - 665
[10] p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas?
Pelosi, G
Pasini, F
Stenholm, CO
Pastorino, U
Maisonneuve, P
Sonzogni, A
Maffini, F
Pruneri, G
Fraggetta, F
Cavallon, A
Roz, E
Iannucci, A
Bresaola, E
Viale, G
JOURNAL OF PATHOLOGY, 2002, 198 (01): : 100 - 109

← 1 2 →